
KKI-5
CAS No. 97145-43-2
KKI-5 ( —— )
产品货号. M30490 CAS No. 97145-43-2
KKI 5 is a serine protease inhibitor that inhibits kallikrein and plasmin. KKI 5 may exhibit anticancer chemotherapeutic benefit and may also be used as a treatment for angioedema.
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1260 | 有现货 |
![]() ![]() |
10MG | ¥2268 | 有现货 |
![]() ![]() |
100MG | 获取报价 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称KKI-5
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述KKI 5 is a serine protease inhibitor that inhibits kallikrein and plasmin. KKI 5 may exhibit anticancer chemotherapeutic benefit and may also be used as a treatment for angioedema.
-
产品描述KKI 5 is a serine protease inhibitor that inhibits kallikrein and plasmin. KKI 5 may exhibit anticancer chemotherapeutic benefit and may also be used as a treatment for angioedema.(In Vitro):The KKI-5 Peptide corresponds to aa386-391 of bovine kininogen-1 that encompasses the aa388-389 kallikrein proteolytic site. The synthetic KKI-5 can attenuate breast cancer cell invasion, therefore it is investigated for its role in invasion and metastasis of cancer cells.
-
体外实验The KKI-5 Peptide corresponds to aa386-391 of bovine kininogen-1 that encompasses the aa388-389 kallikrein proteolytic site. The synthetic KKI-5 can attenuate breast cancer cell invasion, therefore it is investigated for its role in invasion and metastasis of cancer cells.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Kallikrein Inhibitor
-
研究领域——
-
适应症——
化学信息
-
CAS Number97145-43-2
-
分子量773.88
-
分子式C35H55N11O9
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称Sequence:Ac-Pro-Phe-Arg-Ser-Val-Gln-NH2
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
Deshpande MS, et al. Mapping the binding site of tissue kallikrein: preparation and testing of all possible substrate analog inhibitors homologous with the sequence of kininogen between Ser386 and Gln392. J Med Chem. 1992 Aug 21;35(17):3094-102.
产品手册




关联产品
-
Nifursol
Nifursol 是一种牲畜饲料添加剂和抗生素,用于防止组织单胞菌的生长。
-
ND-646
ND-646 是一种口服生物可利用的 ACC 酶 ACC1 和 ACC2 变构抑制剂(重组 hACC1 和 hACC2 的 IC50 分别为 3.5 nM 和 4.1 nM) ND-646 - ACC 酶的变构抑制剂。 ACC1 和 ACC2 阻止 ACC 亚基二聚化,从而抑制体外和体内脂肪酸合成。
-
Cinaciguat
Cinaciguat (BAY 58-2667) 是临床开发中第一种新型可溶性鸟苷酸环化酶 (sGC) 激活剂,用于治疗急性失代偿性心力衰竭。